Istituto Clinico Humanitas
Rozzano, Milan, 20089, Italy
NCT Number: NCT00491140
The primary objective is to identify molecular features predicting response or resistance to cetuximab
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Rozzano, Milan, 20089, Italy
Secondary objective is to investigate association of genomic status of EGFR and HER-2 genes with clinical outcome, including objective response, time to progression and survival
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
FISH and mutation analysis of multiple genes
Time frame: Assessment every two months
Time frame: At the end of the study
Looking for future studies?
Notify MeIstituto Clinico Humanitas
Other
Retrospective Study Assessing Molecular Features Predicting Response or Resistance to Cetuximab Therapy in Metastatic Colorectal Cancer Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07838246
Colonic Diseases, Colorectal Cancer (CRC)
Milan, Italy
View Trial DetailsNCT06805123
Colonic Diseases, Colorectal Neoplasms
Busan, South Korea
View Trial DetailsNCT05754229
Colonic Diseases, Colorectal Adenoma
Holbæk, Denmark
View Trial DetailsNCT07784114
Colitis, Colitis, Ulcerative
View Trial Details